Rosty Raykov is Director at FENNEC PHARMACEUTICALS INC. (FENC). They have made 5 open-market trades across 1 company since 2022, most recently 2026-09-01.
CIK 0001468316
Unrated. We grade insiders only on stock they chose to buy on the open market. Grants, option exercises and vesting say nothing about timing, so they don't count — which is why someone can file often and still have no grade. It isn't a bad sign: unrated buys beat every graded tier below A.
0 open-market purchases, against 5 sales. Too few scored purchases to measure a record yet.
| Ticker | Shares | Value |
|---|---|---|
| FENC | 124,411 | $1.2M |
Shares reported on the most recent Form 4, priced at the 2026-09-01 close.
Counted per filing, not per execution lot — a purchase filled in several tranches is one decision.
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| FENC | SELL · 10b5-1 | 2026-09-01 | 2026-09-01 | $12.11 | $121K | -12.3% | -15.5% | — |
| FENC | SELL · 10b5-1 | 2026-08-03 | 2026-08-04 | $9.58 | $96K | +14.5% | +22.3% | — |
| FENC | SELL · 10b5-1 | 2026-07-01 | 2026-07-02 | $10.41 | $100K | -1.8% | -11.4% | -1.4% |
| FENC | SELL · 10b5-1 | 2026-06-01 | 2026-06-02 | $9.62 | $94K | -5.1% | +13.0% | +30.3% |
| FENC | SELL · 10b5-1 | 2026-05-01 | 2026-05-01 | $6.47 | $70K | +0.4% | +46.8% | +47.4% |
| FENC | SELL · 10b5-1 | 2026-04-01 | 2026-04-02 | $6.31 | $69K | +2.5% | +4.7% | +62.7% |
| FENC | SELL · 10b5-1 | 2026-03-02 | 2026-03-03 | $8.36 | $84K | -6.9% | -20.5% | +22.2% |
| FENC | SELL · 10b5-1 | 2026-02-02 | 2026-02-02 | $7.76 | $80K | +5.5% | +5.5% | -14.5% |
| FENC | SELL | 2026-01-02 | 2026-01-05 | $7.60 | $78K | -0.3% | +6.1% | -14.2% |
| FENC | SELL · 10b5-1 | 2025-12-05 | 2025-12-05 | $7.54 | $75K | -0.7% | -1.2% | +4.5% |
| FENC | SELL · 10b5-1 | 2025-11-05 | 2025-11-06 | $8.10 | $81K | +9.8% | -5.4% | -0.4% |
| FENC | SELL · 10b5-1 | 2025-10-06 | 2025-10-06 | $9.78 | $98K | -11.1% | -15.1% | -22.8% |
| FENC | SELL · 10b5-1 | 2025-09-04 | 2025-09-04 | $8.92 | $89K | -3.8% | +5.9% | -17.7% |
| FENC | SELL · 10b5-1 | 2025-08-05 | 2025-08-05 | $8.09 | $81K | +3.1% | +13.2% | +0.2% |
| FENC | SELL · 10b5-1 | 2025-07-03 | 2025-07-07 | $8.61 | $86K | +2.1% | -4.8% | +13.7% |
| FENC | SELL · 10b5-1 | 2025-06-05 | 2025-06-06 | $7.78 | $78K | -6.5% | +0.7% | +9.2% |
| FENC | SELL | 2025-05-16 | 2025-05-19 | $6.78 | $226K | +0.2% | -3.0% | +1.2% |
| FENC | SELL · 10b5-1 | 2025-05-05 | 2025-05-05 | $6.31 | $126K | +7.2% | +25.6% | +36.2% |
| FENC | SELL · 10b5-1 | 2025-04-04 | 2025-04-04 | $5.25 | $53K | -0.4% | +22.7% | +71.9% |
| FENC | SELL · 10b5-1 | 2025-03-05 | 2025-03-06 | $6.79 | $68K | -1.9% | -22.2% | +14.6% |
| FENC | SELL · 10b5-1 | 2025-02-05 | 2025-02-05 | $6.66 | $67K | -1.7% | +0.3% | -12.4% |
| FENC | SELL · 10b5-1 | 2025-01-06 | 2025-01-07 | $6.08 | $61K | -5.3% | +9.9% | -14.0% |
| FENC | SELL · 10b5-1 | 2024-12-05 | 2024-12-05 | $6.04 | $5K | +5.9% | +6.1% | +17.8% |
| FENC | SELL · 10b5-1 | 2024-12-03 | 2024-12-04 | $6.13 | $10K | -1.5% | +1.8% | +11.4% |
| FENC | SELL · 10b5-1 | 2024-11-04 | 2024-11-04 | $4.31 | $10K | -4.8% | +31.4% | +40.7% |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.